DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,993 filers reported holding DANAHER CORPORATION in Q3 2022. The put-call ratio across all filers is 1.00 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $857 | +3.6% | 3,454 | +0.3% | 0.08% | +9.9% |
Q2 2023 | $827 | -4.3% | 3,444 | +0.4% | 0.07% | -10.1% |
Q1 2023 | $864 | -9.9% | 3,429 | -5.1% | 0.08% | -12.2% |
Q4 2022 | $959 | -99.9% | 3,614 | 0.0% | 0.09% | -9.1% |
Q3 2022 | $933,000 | +1.9% | 3,614 | 0.0% | 0.10% | +6.5% |
Q2 2022 | $916,000 | +5.8% | 3,614 | +22.3% | 0.09% | +25.7% |
Q1 2022 | $866,000 | -10.9% | 2,954 | 0.0% | 0.07% | -10.8% |
Q4 2021 | $972,000 | +8.1% | 2,954 | 0.0% | 0.08% | 0.0% |
Q3 2021 | $899,000 | +13.4% | 2,954 | 0.0% | 0.08% | +15.3% |
Q2 2021 | $793,000 | +19.2% | 2,954 | 0.0% | 0.07% | +12.5% |
Q1 2021 | $665,000 | +1.8% | 2,954 | +0.5% | 0.06% | -8.6% |
Q4 2020 | $653,000 | -5.2% | 2,939 | -8.2% | 0.07% | -14.6% |
Q3 2020 | $689,000 | +21.7% | 3,201 | 0.0% | 0.08% | +13.9% |
Q2 2020 | $566,000 | +11.2% | 3,201 | -12.9% | 0.07% | -1.4% |
Q1 2020 | $509,000 | -17.6% | 3,676 | -8.7% | 0.07% | +12.3% |
Q4 2019 | $618,000 | +5.8% | 4,026 | -0.4% | 0.06% | +3.2% |
Q3 2019 | $584,000 | -0.2% | 4,042 | -1.2% | 0.06% | +1.6% |
Q2 2019 | $585,000 | +7.5% | 4,092 | -0.6% | 0.06% | +3.3% |
Q1 2019 | $544,000 | +28.0% | 4,117 | 0.0% | 0.06% | +20.0% |
Q4 2018 | $425,000 | -4.5% | 4,117 | +0.6% | 0.05% | +13.6% |
Q3 2018 | $445,000 | +10.1% | 4,092 | 0.0% | 0.04% | +2.3% |
Q2 2018 | $404,000 | -0.5% | 4,092 | -1.2% | 0.04% | +2.4% |
Q1 2018 | $406,000 | +5.7% | 4,142 | 0.0% | 0.04% | +7.7% |
Q4 2017 | $384,000 | +8.2% | 4,142 | 0.0% | 0.04% | +2.6% |
Q3 2017 | $355,000 | +53.0% | 4,142 | +50.5% | 0.04% | +46.2% |
Q2 2017 | $232,000 | +3.1% | 2,752 | +4.4% | 0.03% | +4.0% |
Q1 2017 | $225,000 | +10.3% | 2,635 | +0.4% | 0.02% | +4.2% |
Q4 2016 | $204,000 | – | 2,625 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
Third Point | 2,450,000 | $607,845,000 | 9.22% |
Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |